KORU Medical Systems, Inc.
For the period ended Jun 30, 2025. Filed Aug 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 6, 2025
KRMD$3.09+2.0%Stored close · as of Nov 6, 2026
Contents
Balance Sheets as of June 30, 2025 (Unaudited) and December 31, 2024
BALANCE SHEETS
| June 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| (UNAUDITED) | ||
| ASSETS | ||
| CURRENT ASSETS | ||
| Cash and cash equivalents | $8,054,716 | $9,580,947 |
| Accounts receivable less allowance for credit losses of $0 as of June 30, 2025 and December 31, 2024 | 4,929,071 | 5,720,750 |
| Inventory | 3,947,843 | 2,803,669 |
| Other receivables | 161,190 | 277,193 |
| Prepaid expenses | 486,524 | 749,851 |
| TOTAL CURRENT ASSETS | 17,579,344 | 19,132,410 |
| Property and equipment, net | 4,370,629 | 4,290,515 |
| Intangible assets, net of accumulated amortization of $493,244 and $458,538 as of June 30, 2025 and December 31, 2024, respectively | 698,974 | 730,279 |
| Operating lease right-of-use assets | 2,768,376 | 2,966,341 |
| Other assets | 98,970 | 98,970 |
| TOTAL ASSETS | $25,516,293 | $27,218,515 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES | ||
| Accounts payable | $1,094,539 | $1,649,969 |
| Accrued expenses | 3,635,525 | 3,924,184 |
| Note payable | — | 271,152 |
| Other liabilities | 104,102 | 29,269 |
| Accrued payroll and related taxes | 688,942 | 811,401 |
| Financing lease liability – current | 118,647 | 115,587 |
| Operating lease liability – current | 409,019 | 400,258 |
| TOTAL CURRENT LIABILITIES | 6,050,774 | 7,201,820 |
| Financing lease liability, net of current portion | 145,469 | 202,613 |
| Operating lease liability, net of current portion | 2,793,676 | 3,000,403 |
| TOTAL LIABILITIES | 8,989,919 | 10,404,836 |
| STOCKHOLDERS’ EQUITY | ||
| Common stock, $0.01 par value, 75,000,000 shares authorized, 49,655,459 and 49,377,617 shares issued 46,234,957 and 45,957,115 shares outstanding as of June 30, 2025, and December 31, 2024, respectively | 496,555 | 493,776 |
| Additional paid-in capital | 50,664,323 | 49,581,303 |
| Treasury stock, 3,438,526 shares as of June 30, 2025 and December 31, 2024, at cost | (3,882,494) | (3,882,494) |
| Accumulated deficit | (30,752,010) | (29,378,906) |
| TOTAL STOCKHOLDERS’ EQUITY | 16,526,374 | 16,813,679 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $25,516,293 | $27,218,515 |
- 3 -
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.